NIH-Sponsored Trial of Nasal COVID-19 Vaccine Opens
July 02, 2024
July 02, 2024
WASHINGTON, July 2 -- The U.S. Department of Health and Human Services' National Institutes of Health issued the following news release on July 1, 2024:
* * *
Candidate vaccine could provide enhanced breadth of protection against emerging SARS-CoV-2 variants.
* * *
A Phase 1 trial testing the safety of an experimental nasal vaccine that may provide enhanced breadth of protection against emerging variants of SARS-CoV-2, the virus that causes COV . . .
* * *
Candidate vaccine could provide enhanced breadth of protection against emerging SARS-CoV-2 variants.
* * *
A Phase 1 trial testing the safety of an experimental nasal vaccine that may provide enhanced breadth of protection against emerging variants of SARS-CoV-2, the virus that causes COV . . .